Related Experiment Video

Updated: Jun 29, 2025

Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
08:32

Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media

Published on: February 12, 2019

13.7K

Stem Cell-Derived Extracellular Vesicles in the Treatment of Cardiovascular Diseases

Jennifer McDonald1, Sidhesh Mohak2, Zsolt Fabian1

  • 1School of Medicine and Dentistry, Faculty of Clinical and Biomedical Sciences, University of Central Lancashire, Fylde Road, Preston PR1 2HE, UK.

Pharmaceutics
|March 28, 2024
PubMed

Insights

Stem cell-derived extracellular vesicles show promise for treating cardiovascular diseases. These vesicles offer a novel therapeutic approach to address challenges in managing heart conditions and improving patient outcomes.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Cardiovascular disease (CVD) presents a significant global health burden with high incidence and mortality.
  • Clinical management of CVD faces challenges including medication complexity and lack of systematic decision-making.
  • Existing interventions highlight the need for innovative therapeutic strategies.

Purpose of the Study:

  • To explore the therapeutic potential of stem cell-derived extracellular vesicles (EVs) in cardiovascular pathologies.
  • To provide an overview of current understanding regarding stem cell-derived EVs in managing human heart conditions.
  • To highlight the role of EVs in regenerative medicine for cardiovascular applications.

Main Methods:

  • Literature review and synthesis of current research on stem cell-derived EVs.
  • Analysis of the molecular composition and functional properties of EVs.
  • Overview of preclinical and clinical evidence for EV-based cardiovascular therapies.

Main Results:

  • Stem cell-derived EVs possess a unique molecular fingerprint (lipids, proteins, nucleic acids).
  • EVs exhibit multifaceted functions relevant to cardio-protection and tissue regeneration.
  • These vesicles represent a promising platform for novel therapeutic interventions in CVD.

Conclusions:

  • Stem cell-derived EVs hold significant therapeutic potential for cardiovascular diseases.
  • Further research into their mechanisms of action can advance regenerative medicine.
  • EVs offer a promising avenue for improving the clinical management of human cardiovascular pathologies.

Keywords:
cardiovascular diseasesexosomesmicrovesiclesregenerative medicinestem cell-derived extracellular vesicles

More Related Videos

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.0K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.1K

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K